Follow Us:
Webinars

The Neurosurgery Research & Education Foundation (NREF) expanded its informational and educational offerings with a complimentary webinar series.

UPCOMING: Strategic use of BCNU Wafers in Contemporary Care

Date(s)

  • August 23rd at 7 PM EDT / 6 PM CDT
  • August 30th at 9 PM EDT / 8 PM CDT

Faculty
Lynn Stuart Ashby, MD
Assistant Director, Neuro Oncology Program
Barrow Neurological Institute, Phoenix, Arizona

Eyas M. Hattab, MD, MBA
AJ Miller Professor and Chair,
Pathology and Laboratory Medicine, Louisville, KY

Timothy C. Ryken, MD, MS, FACS, FAANS
Professor and Chief, Section of Neurosurgery
Dartmouth-Hitchcock Medical Center, Lebanon, NH

Learning Objectives

  • Review historical changes in incidence and survival over recent decades for high grade malignant glioma (HGG) and summarize current FDA approved treatments
  • Evaluate pivotal evidence for the use of BCNU wafers and indications for newly diagnosed and recurrent HGG setting
  • Develop strategic approach for integrating BCNU wafers  into multimodal standard treatment for patients at diagnosis and relapse of HGG
  • Discuss prerequisites for successful intraoperative consultation (IOC) outcomes and overcoming challenges in surgical neuropathology
  • Learn how to bridge the intraoperative gap between pathology and neurosurgery
  • Identify the best operative and post -operative approaches toward optimizing outcomes following BCNU wafer implantation

This complimentary NREF webinar is provided with support from Arbor Pharmaceuticals.

To register, please visit: https://education.aans.org/products/strategic-use-of-bcnu-wafers-in-contemporary-care

Dates and topics for future webinars will be forthcoming.

Have a suggestion for a future webinar? Please send your ideas to the NREF staff at info@nref.org.

Past Webinars:

Current Applications and Advances in Fluorescence-guided Surgery.

Speaker: Costas G. Hadjipanayis, MD, PhD, FAANS

Director of Neurosurgical Oncology and Chair, Department of Neurosurgery, Mt. Sinai Beth Israel

Director, Brain Tumor Nanotechnology Laboratory, Tisch Cancer Institute
Description: Participants will receive an overview on the concept of fluorescence-guided surgery (FGS) for the resection of brain and spinal cord tumors. Neurosurgeons will understand the current technologies available for FGS and the different tumor types that can undergo FGS. Safety, diagnostic accuracy, and Level 1 evidence in support of FGS will also be discussed.

This complimentary NREF webinar was provided with support from Leica Microsystems.

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid (5-ALA) for Fluorescence-guided Surgery of Brain Tumors?

Speaker: Costas G. Hadjipanayis, MD, PhD, FAANS

Director of Neurosurgical Oncology and Chair, Department of Neurosurgery, Mt. Sinai Beth Israel

Director, Brain Tumor Nanotechnology Laboratory, Tisch Cancer Institute
Description: Participants will receive an overview on the concept of fluorescence-guided surgery (FGS) for the resection of brain and spinal cord tumors. Neurosurgeons will understand the current technologies available for FGS and the different tumor types that can undergo FGS. Safety, diagnostic accuracy, and Level 1 evidence in support of FGS will also be discussed.

This complimentary NREF webinar was provided with support from Leica Microsystems.
| |